RECENT PLACEMENT

Occam Recruits Sapna Srivastava to the Board of Nuvalent

Occam Recruits Sapna Srivastava to the Board of Nuvalent

Nuvalent, an F-Prime/Deerfield investment, develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events and drive more durable responses. The company went public in 2021 generating $166M.

In late 2021, Occam recruited Sapna Srivastava, PhD to the Board of Nuvalent. Sapna began her career as an equity analyst on Wall Street before taking on operating CFO roles at innovative biotechs like eGenesis, VelosBio, and Intellia.

‍

Recent Placements

  1. John Reynders as Chief Data Sciences Officer of Neumora
  2. Jevan Soo Lenox as Chief People Officer at insitro
  3. Jorge Bartolome as CEO at Areteia Therapeutics
  4. Kevin Coveney as CFO of Enveric Biosciences
  5. Gurpreet Ratra as CBO at Skyline
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.